BioDay Registry: Data Collection Regarding the Use of New Systemic Treatment Options in Patients with Atopic Dermatitis
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Eli Lilly and Company
Related studies linked through entity extraction aliases.
A Study of Lanabecestat in Participants With Severe Kidney Impairment Compared to Healthy Participants
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
- Status
- COMPLETED
- Phase
- PHASE3
Fulvestrant Plus Abemaciclib in Women With Advanced Low Grade Serous Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Nivolumab Plus Ramucirumab in Patients With Recurrent, Advanced, Metastatic NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis
- Status
- COMPLETED
- Phase
- PHASE3
RAMucirumab in Combination Wth TAS102 vs. TAS102 Alone in Chemotherapy Refractory Metastatic Colorectal Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Lanabecestat in Healthy Female Participants Taking Oral Contraceptive
- Status
- WITHDRAWN
- Phase
- PHASE1
Phase II Nivolumab and Ramucirumab for Patients With Previously-Treated Mesothelioma
- Status
- TERMINATED
- Phase
- PHASE2
A Study of LY3314814 in Participants With Liver Impairment
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study of Prexasertib (LY2606368), CHK1 Inhibitor, and LY3300054, PD-L1 Inhibitor, in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Ixekizumab in the Treatment of Pityriasis Rubra Pilaris (PRP)
- Status
- COMPLETED
- Phase
- PHASE2
Are the "Cardiac Benefits" of Empagliflozin Independent of Its Hypoglycemic Activity? (ATRU-4).
- Status
- COMPLETED
- Phase
- PHASE4
Vinorelbine in Advanced BRAF-like Colon Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Tirzepatide (LY3298176) in Participants With Impaired Kidney Function
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Participants With Moderate-to-Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3